United States · Funded startup
7 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$111Mraised across 7 rounds since 2009, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $20M sold, first sale Jan 2015
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Apr 2014
Reported by finsmes.comSEC filing: $24M sold, first sale Jul 2012
No investor was named in the report.
Reported by fiercebiotech.comSEC filing: $23M sold, first sale May 2010
No investor was named in the report.
Reported by sec.govSEC filing: $989K sold, first sale Apr 2010
No investor was named in the report.
Reported by sec.govSEC filing: $1.0M sold, first sale Dec 2009
No investor was named in the report.
Reported by sec.govSEC filing: $1.0M sold, first sale Oct 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Investor AB
Kaiser Permanente Ventures
Aisling Capital
ProQuest InvestmentsCare CapitalNovitas CapitalMissing a round, or an investor who was in one? Tell us.
Agile Therapeutics's investors include Investor AB, Kaiser Permanente Ventures, Aisling Capital, ProQuest Investments and Care Capital, and 1 more on record.
Agile Therapeutics has raised $111M across 7 rounds since 2009.
Agile Therapeutics's most recent round was an Undisclosed round of $20M in Feb 2015.
Agile Therapeutics's largest round on record is $45M (Series B), in Jun 2010.
Agile Therapeutics's first round on record, in Jul 2012, was backed by Investor AB, Kaiser Permanente Ventures and Aisling Capital and 3 others.
Agile Therapeutics's latest named round is an Undisclosed round, in Feb 2015.
Agile Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·